Severe hypotension associated with angiotensin-converting enzyme inhibition in anaesthesia

Anaesthesia and Intensive Care

Volumn 26, Issue 1, 1998, Pages 107-109

  Powell, C G ^a   Unsworth, D J ^a   McVey, F K ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Blood pressure: hypertension, hypotension, angiotensin converting enzyme inhibitors; Blood: volume, replacement, colloid, gelofusine; Complications: hypotension, oedema, bronchospasm

Indexed keywords

AMILORIDE; BENDROFLUMETHIAZIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GELATIN SUCCINATE; LISINOPRIL;

AGED; ANESTHESIA; ARTICLE; BLOOD PRESSURE; BRONCHOSPASM; CASE REPORT; COLLOID; EDEMA; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; ORAL DRUG ADMINISTRATION;

EID: 0031887417     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9802600122     Document Type: Article

References (5)

1. Costerousse O, Jaspard E, Wei L, Corvol P, Alhenc-Gelas F. The angiotensin I converting enzyme (kininase II): molecular organisation and regulation of its expression in humans. J Cardiovasc Pharmacol 1992; 20(Suppl 9): S10-S15.
2. Bonner G, Preis S, Schunk U, Wagmann M, Chrosch R, Toussaint C. Effect of bradykinin on arteries and veins in systemic and pulmonary circulation. J Cardiovasc Pharmacol 1992; 20(Suppl 9):S21-S27.
3. Mombouli JV, Vanhoutte PM. Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: Role of bradykinin generation during ACE inhibition. J Cardiovasc Pharmacol 1992; 20(Suppl 9): S74-S83.
4. Schror K. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1992; 20(Suppl 9): S68-S73.
5. Owen HG, Brecher ME. Atypical reactions associated with the use of angiotensin-converting enzyme inhibitors and apheresis. Transfusion 1994; 34(10):891-894.